Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema.

Authors

Fatih Bilgehan Kaplan, Ecem Önder Tokuç, Erdinç Bozkurt, Abdullah Özkaya, Hatice Selen Kanar, Mehmet Orkun Sevik, Işıl Kutlutürk Karagöz, Uğur Yayla, Erkan Çelik, Ayşe Demirciler Sönmez, Aslan Aykut, Esra Türkseven Kumral, Nimet Yeşim Erçalık, Özlem Aydın Öncü, Işılay Özsoy Saygın, Tuğba Aydoğan Gezginaslan, Utku Limon, Ece Başaran Emengen, Banu Açıkalın, Nursal Melda Yenerel, Özlem Şahin, V Levent Karabaş

Published in

European journal of ophthalmology. Pages 11206721261480211. Aug 21, 2026. Epub Aug 21, 2026.

Abstract

PurposeTo compare baseline optical coherence tomography (OCT) characteristics and early visual response for predicting 12-month visual outcomes in eyes with diabetic macular edema (DME) treated with anti-vascular endothelial growth factor (anti-VEGF) therapy in a real-world setting.MethodsThis multicenter, retrospective, longitudinal study included 255 treatment-naïve patients (337 eyes) with DME who received intravitreal ranibizumab or aflibercept using a pro-re-nata regimen following three loading doses. Baseline OCT biomarkers and changes in best-corrected visual acuity (BCVA) at month 3 were evaluated as predictors of visual improvement at month 12. Generalized estimating equation (GEE) logistic regression models accounted for inter-eye correlation and model discrimination was assessed using receiver operating characteristic analysis.ResultsAt month 3, 58.4% of eyes achieved at least a one-line improvement in BCVA. Early BCVA improvement was associated with visual gain at month 12 (odds ratio [OR] 5.78, 95% confidence interval [CI] 3.34-9.99, p < 0.001). Among baseline OCT parameters, preserved ellipsoid zone integrity (OR, 3.07; 95% CI, 1.09-8.64; p = 0.034) and absence of vitreomacular interface abnormalities (OR, 2.64; 95% CI, 1.02-6.84; p = 0.046) were associated with favorable outcomes. ROC analysis based on GEE-predicted probabilities showed higher discriminative ability for the early visual response model than for the baseline OCT model (AUC, 0.817; 95% CI, 0.768-0.865 vs. AUC, 0.766; 95% CI, 0.714-0.819; DeLong test, p = 0.037).ConclusionBaseline OCT features provide useful pretreatment prognostic information; however, early visual response after the loading phase offers additional dynamic prognostic insight. These findings suggest that final prognostic judgment should not rely solely on baseline OCT morphology and should be refined after the initial treatment response is assessed.

PMID:
42630057
Bibliographic data and abstract were imported from PubMed on 22 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.